HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis

Multiple Sclerosis

Volumn 16, Issue 1, 2010, Pages 21-29

  Guimarães Brum, Doralina ^a   Barreira, Amilton Antunes ^a   Dos Santos, Antonio Carlos ^a   Kaimen Maciel, Damacio Ramon ^b   Matiello, Marcelo ^a,c   Costa, Roberta Martins ^a   Saloun Deghaide, Neifi Hassan ^b   Silva Costa, Laudo ^a   Louzada Junior, Paulo ^a   Beserra Diniz, Paula Rejane ^a   Comini Frota, Elizabeth Regina ^d   Mendes Junior, Celso Teixeira ^a   Donadi, Eduardo Antonio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b STATE UNIVERSITY OF LONDRINA   (Brazil)

^c MAYO CLINIC   (United States)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Anti aquaporin 4; Brazilians; HLA DR; Multiple sclerosis; Neuromyelitis optica

Indexed keywords

HLA DR ANTIGEN;

ADULT; ARTICLE; BRAZIL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; HLA TYPING; HUMAN; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; SPINAL CORD LESION;

ADULT; AGE OF ONSET; AGED; ALLELES; BLOOD DONORS; BRAZIL; FEMALE; GENE FREQUENCY; HISTOCOMPATIBILITY TESTING; HLA-DR ANTIGENS; HUMANS; IMMUNOGLOBULIN G; LINKAGE (GENETICS); MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA;

EID: 73949128856     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509350741     Document Type: Article

References (38)

1. Wingerchuk DM, Hogancamp WF, OBrien PC, Weinshenker BG The clinical course of neuromyelitis optica (Devics syndrome). Neurology 1999 ; 53: 1107-1114.
2. Pittock SJ, Lennon VA, Krecke K., Wingerchuk DM, Lucchinetti CF, Weinshenker BG Brain abnormalities in neuromyelitis optica. Arch Neurol 2006 ; 63: 390-396.
3. Bichuetti DB, Rivero RL, Oliveira DM, et al. Neuromyelitis optica: brain abnormalities in a Brazilian cohort. Arq Neuropsiquiatr 2008 ; 66: 1-4.
4. Roemer SF, Parisi JE, Lennon VA, et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 2007 ; 130: 1194-1205.
5. Misu T., Fujihara K., Kakita A., et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 2007 ; 130: 1224-1234.
6. Mandler RN, Ahmed W., Dencoff JE Devics neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology 1998 ; 51: 1219-1220.
7. Papeix C., Vidal JS, de Seze J., et al. Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler 2007 ; 13: 256-259.
8. Jacob A., Weinshenker BG, Violich I., et al. Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients. Arch Neurol 2008 ; 65: 1443-1448.
9. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004 ; 364: 2106-2112.
10. Weinshenker BG, Wingerchuk DM, Vukusic S., et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 2006 ; 59: 566-569.
11. Matiello MLV, Jacob A., Pittock SJ, Lucchinetti CF, Wingerchuk DM, Weinshenker BG NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 2008 ; 70: 2192-2193.
12. Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol 2003 ; 2: 117-127.
13. Cabre P., Heinzlef O., Merle H., et al. MS and neuromyelitis optica in Martinique (French West Indies). Neurology 2001 ; 56: 507-514.
14. Osuntokun BO The pattern of neurological illness in tropical Africa. Experience at Ibadan, Nigeria. J Neurol Sci 1971 ; 12: 417-442.
15. Callegaro D., Goldbaum M., Morais L., et al. The prevalence of multiple sclerosis in the city of Sao Paulo, Brazil, 1997. Acta Neurol Scand 2001 ; 104: 208-213.
16. Ferreira ML, Machado MI, Vilela ML, et al. Epidemiology of 118 cases of multiple sclerosis after 15 years of follow-up on the reference center of Hospital da Restauracao, Recife, Pernambuco, Brazil. Arq Neuropsiquiatr 2004 ; 62: 1027-1032.
17. Adoni T., Lino AM, Marchiori PE, Kok F., Callegaro D. Seroprevalence of NMO-IgG antibody in Brazilian patients with neuromyelitis optica. Arq Neuropsiquiatr 2008 ; 66: 295-297.
18. Lana-Peixoto MA, Lana-Peixoto MI Is multiple sclerosis in Brazil and Asia alike? Arq Neuropsiquiatr 1992 ; 50: 419-425.
19. Papais-Alvarenga R., Miranda-Santos C., Puccioni-Sohler M., et al. Optic neuromyelitis syndrome in Brazilian patients. J Neurol Neurosurg Psychiatry 2002 ; 73: 429-435.
20. Shriver MD, Parra EJ, Dios S., et al. Skin pigmentation, biogeographical ancestry and admixture mapping. Hum Genet 2003 ; 112: 387-399.
21. Muniz YC, Ferreira LB, Mendes-Junior CT, Wiezel CE, Simoes AL Genomic ancestry in urban Afro-Brazilians. Ann Hum Biol 2008 ; 35: 104-111.
22. Ibge. Síntese dos indicadores - 2006. Rio de Janeiro: Instituto Brasileiro Geografia Estatística (IBGE), 2006.
23. Oksenberg JR, Barcellos LF, Cree BA, et al. Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet 2004 ; 74: 160-167.
24. Brum DG, Barreira AA, Louzada-Junior P., Mendes-Junior CT, Donadi EA Association of the HLA-DRB1*15 allele group and the DRB1*1501 and DRB1*1503 alleles with multiple sclerosis in White and Mulatto samples from Brazil. J Neuroimmunol 2007 ; 189: 118-124.
25. Alves-Leon SV, Papais-Alvarenga R., Magalhaes M., Alvarenga M., Thuler LC, Fernandez Y., Fernandez O. Ethnicity-dependent association of HLA DRB1-DQA1-DQB1 alleles in Brazilian multiple sclerosis patients. Acta Neurol Scand 2007 ; 115: 306-311.
26. Kira J., Kanai T., Nishimura Y., et al. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol 1996 ; 40: 569-574.
27. Yamasaki K., Horiuchi I., Minohara M., et al. HLA-DPB1*0501- associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies. Brain 1999 ; 122: 1689-1696.
28. Zephir H., Fajardy I., Outteryck O., et al. Is neuromyelitis optica associated with human leukocyte antigen? Mult Scler 2009 ; in press.
29. Kurtzke JF Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983 ; 33: 1444-1452.
30. Barkhof F., Filippi M., Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997 ; 120: 2059-2069.
31. Raymond M. aFR population genetics software for exact tests and ecumenicism. J Hered 1995 ; 86: 248-249.
32. Marrosu MG, Murru MR, Costa G., Murru R., Muntoni F., Cucca F. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population. Hum Mol Genet 1998 ; 7: 1235-1237.
33. Masterman T., Ligers A., Olsson T., Andersson M., Olerup O., Hillert J. HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol 2000 ; 48: 211-219.
34. Pittock SJ, Lennon VA, de Seze J., et al. Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 2008 ; 65: 78-83.
35. Matsuoka T., Matsushita T., Osoegawa M., et al. Association of the HLA-DRB1 alleles with characteristic
36. MRI features of Asian multiple sclerosis. Mult Scler 2008 ; 14: 1181-1190.
37. Cree BA, Reich DE, Khan O., et al. Modification of multiple sclerosis phenotypes by African ancestry at HLA. Arch Neurol 2009 ; 66: 226-233.
38. DeLuca GC, Ramagopalan SV, Herrera BM, et al. An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus. Proc Natl Acad Sci U S A 2007 ; 104: 20896-20901.